These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 21151200)

  • 81. Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy.
    Chen Z; Li W; Shi L; Jiang L; Li M; Zhang C; Peng H
    Eur J Pharm Biopharm; 2020 Nov; 156():143-154. PubMed ID: 32937179
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ursodeoxycholic Acid Ameliorated Diabetic Nephropathy by Attenuating Hyperglycemia-Mediated Oxidative Stress.
    Cao A; Wang L; Chen X; Guo H; Chu S; Zhang X; Peng W
    Biol Pharm Bull; 2016 Aug; 39(8):1300-8. PubMed ID: 27193377
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [The total antioxidant capacity and low-molecular antioxidant concentration in plasma of type-2 diabetes patients with different stage of metabolic compensation and concomitant diabetic nephropathy].
    Błaszczak R; Kujawski K; Kedziora-Kornatowska K; Kornatowski T; Kedziora J; Szadujkis-Szadurski L; Markuszewski L; Rysz J; Ertel D; Olszewski R
    Pol Merkur Lekarski; 2005 Jan; 18(103):29-32. PubMed ID: 15859542
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The relationship between glucose control and the development and progression of diabetic nephropathy.
    Phillips CA; Molitch ME
    Curr Diab Rep; 2002 Dec; 2(6):523-9. PubMed ID: 12643159
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Combating diabetic nephropathy with drug therapy.
    Martins D; Norris K
    Curr Diab Rep; 2001 Oct; 1(2):148-56. PubMed ID: 12643111
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy.
    Palm F
    Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):997-1001. PubMed ID: 17002679
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Diabetic nephropathy and multiorgan protection. Part II.
    Gluhovschi G; Gluhovschi C; Vlad A; Timar R; Bob F; Velciov S; Bozdog G; Petrica L
    Rom J Intern Med; 2011; 49(4):237-49. PubMed ID: 22568268
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Molecular mechanism of diabetic nephropathy].
    Ohshiro Y; Takasu N
    Nihon Rinsho; 2006 May; 64(5):997-1003. PubMed ID: 16689387
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Antidiabetic and renoprotective effect of Anogeissus acuminata leaf extract on experimentally induced diabetic nephropathy.
    Navale AM; Paranjape A
    J Basic Clin Physiol Pharmacol; 2018 Jul; 29(4):359-364. PubMed ID: 29617268
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Molecular bases of diabetic nephropathy].
    Lagranha CJ; Fiorino P; Casarini DE; Schaan BD; Irigoyen MC
    Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):901-12. PubMed ID: 17934656
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Current update in the management of diabetic nephropathy.
    Van Buren PN; Toto R
    Curr Diabetes Rev; 2013 Jan; 9(1):62-77. PubMed ID: 23167665
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Nephrotic syndrome due to metabolic disease--special reference to diabetic nephropathy].
    Ohga S; Shikata K; Makino H
    Nihon Rinsho; 2004 Oct; 62(10):1907-13. PubMed ID: 15500138
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Kidney Disease in Diabetes Mellitus: Cross-Linking between Hyperglycemia, Redox Imbalance and Inflammation.
    Amorim RG; Guedes GDS; Vasconcelos SML; Santos JCF
    Arq Bras Cardiol; 2019 Jun; 112(5):577-587. PubMed ID: 31188964
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Formononetin attenuates kidney damage in type 2 diabetic rats.
    Oza MJ; Kulkarni YA
    Life Sci; 2019 Feb; 219():109-121. PubMed ID: 30641085
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effects of Spirulina platensis on lipid peroxidation, antioxidant defenses, and tissue damage in kidney of alloxan-induced diabetic rats.
    Gargouri M; Hamed H; Akrouti A; Dauvergne X; Magné C; El Feki A
    Appl Physiol Nutr Metab; 2018 Apr; 43(4):345-354. PubMed ID: 29091744
    [TBL] [Abstract][Full Text] [Related]  

  • 97. In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy.
    Nangaku M; Izuhara Y; Usuda N; Inagi R; Shibata T; Sugiyama S; Kurokawa K; van Ypersele de Strihou C; Miyata T
    Nephrol Dial Transplant; 2005 Dec; 20(12):2661-9. PubMed ID: 16188903
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets.
    Mima A
    J Diabetes Res; 2013; 2013():248563. PubMed ID: 23862164
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Detailed Review of Molecular Pathways and Mechanisms Responsible for the Development and Aggravation of Neuropathy and Nephropathy in Diabetes.
    Chandra P; Sachan N; Saraswat N; Vyawahare N
    Curr Mol Pharmacol; 2024; 17(1):e280323215026. PubMed ID: 37018534
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Oxidative stress and diabetic kidney disease.
    Stanton RC
    Curr Diab Rep; 2011 Aug; 11(4):330-6. PubMed ID: 21557044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.